Open access · CC-BY
via OpenAlex
Plasma Proteomic Biomarkers in Alzheimer’s Disease and Cardiovascular Disease: A Longitudinal Study
Laurie A. Theeke, Ying Liu, Silas Wang, Xingguang Luο, Ramiro Osvaldo Navia, Danqing Xiao, Chun Di Xu, Kesheng Wang, The Alzheimer and Disease Neuroimaging Initiative
International Journal of Molecular Sciences · 2024 · ▲ 10 citations
Abstract
The co-occurrence of Alzheimer’s disease (AD) and cardiovascular diseases (CVDs) in older adults highlights the necessity for the exploration of potential shared risk factors. A total of 566 adults were selected from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database, including 111 individuals with AD, 383 with mild cognitive impairment (MCI), and 410 with CVD. The multivariable linear mixed model (LMM) was used to investigate the associations of AD and CVD with longitudinal changes in 146 plasma proteomic biomarkers (measured at baseline and the 12-month follow-up). The LMM showed that 48 biomarkers were linked to AD and 46 to CVD (p < 0.05). Both AD and CVD were associated with longitudinal changes in 14 biomarkers (α1Micro, ApoH, β2M, BNP, complement C3, cystatin C, KIM1, NGAL, PPP, TIM1, THP, TFF3, TM, and VEGF), and both MCI and CVD were associated with 12 biomarkers (ApoD, AXL, BNP, Calcitonin, CD40, C-peptide, pM, PPP, THP, TNFR2, TTR, and VEGF), suggesting intricate connections between cognitive decline and cardiovascular health. Among these, the Tamm Horsfall Protein (THP) was associated with AD, MCI, CVD, and APOE-ε4. This study provides valuable insights into shared and distinct biological markers and mechanisms underlying AD and CVD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ijms251910751
- Canonical
- link ↗
- Fetched
- 2026-11-04 MST
Cite this
APA
Theeke, L.A., Liu, Y., Wang, S., Luο, X., Navia, R.O., Xiao, D., Xu, C.D., Wang, K., & Initiative, T.A.A.D.N. (2024). Plasma Proteomic Biomarkers in Alzheimer’s Disease and Cardiovascular Disease: A Longitudinal Study. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms251910751
Vancouver
Theeke LA, Liu Y, Wang S, Luο X, Navia RO, Xiao D, et al. Plasma Proteomic Biomarkers in Alzheimer’s Disease and Cardiovascular Disease: A Longitudinal Study. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910751.
BibTeX
@article{laurie2024Plasma,
title = {Plasma Proteomic Biomarkers in Alzheimer’s Disease and Cardiovascular Disease: A Longitudinal Study},
author = {Laurie A. Theeke and Ying Liu and Silas Wang and Xingguang Luο and Ramiro Osvaldo Navia and Danqing Xiao and Chun Di Xu and Kesheng Wang and The Alzheimer and Disease Neuroimaging Initiative},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms251910751},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
New York State Psychiatric Institute 2010
Open access · US-GOV
BAY 94-9172 PET/CT in Cognitively Normal Older Adults, Older Adults With Mild Cognitive Impairment, and Older Adults With Alzheimer's Disease
Brain Imaging and Behavior 2017
Preprint · OA
Association of longitudinal white matter degeneration and cerebrospinal fluid biomarkers of neurodegeneration, inflammation and Alzheimer’s disease in late-middle-aged adults
eLife 2023
Open access · CC-BY
Biological brain age prediction using machine learning on structural neuroimaging data: Multi-cohort validation against biomarkers of Alzheimer’s disease and neurodegeneration stratified by sex
The Lancet 2021
Preprint · OA
Alzheimer's disease
Handbook of clinical neurology 2019
Citation only
Alzheimer's disease
Danish Dementia Research Centre 2022
Open access · US-GOV